United States (US) mRNA Vaccine and Therapeutics Market (2025-2031) | Forecast, Trends, Outlook, Analysis, Competitive Landscape, Industry, Companies, Share, Growth, Value, Size & Revenue, Segmentation

Name: United States (US) mRNA Vaccine and Therapeutics Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Vaccine Type (Self-amplifying mRNA-based Vaccines, Conventional Non-amplifying mRNA-based Vaccines), By Application (Cancer, Infectious Diseases, Autoimmune Diseases, Other), By Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, Other), By End user (Research Laboratories and Organizations, Hospitals, Clinics, Others) And Competitive Landscape

Product Code: ETC9979913	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) mRNA Vaccine and Therapeutics Market Outlook
Market Size of United States (US) mRNA Vaccine and Therapeutics Market, 2024
Forecast of United States (US) mRNA Vaccine and Therapeutics Market, 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Revenues & Volume for the Period 2021- 2031
United States (US) mRNA Vaccine and Therapeutics Market Trend Evolution
United States (US) mRNA Vaccine and Therapeutics Market Drivers and Challenges
United States (US) mRNA Vaccine and Therapeutics Price Trends
United States (US) mRNA Vaccine and Therapeutics Porter's Five Forces
United States (US) mRNA Vaccine and Therapeutics Industry Life Cycle
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Vaccine Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Self-amplifying mRNA-based Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Conventional Non-amplifying mRNA-based Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Autoimmune Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Other for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Treatment Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Monoclonal Antibody for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Other for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By End user for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Research Laboratories and Organizations for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) mRNA Vaccine and Therapeutics Import Export Trade Statistics
Market Opportunity Assessment By Vaccine Type
Market Opportunity Assessment By Application
Market Opportunity Assessment By Treatment Type
Market Opportunity Assessment By End user
United States (US) mRNA Vaccine and Therapeutics Top Companies Market Share
United States (US) mRNA Vaccine and Therapeutics Competitive Benchmarking By Technical and Operational Parameters
United States (US) mRNA Vaccine and Therapeutics Company Profiles
United States (US) mRNA Vaccine and Therapeutics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) mRNA Vaccine and Therapeutics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) mRNA Vaccine and Therapeutics Market - Industry Life Cycle

3.4 United States (US) mRNA Vaccine and Therapeutics Market - Porter's Five Forces

3.5 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

3.6 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.8 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F

4 United States (US) mRNA Vaccine and Therapeutics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of infectious diseases and pandemics driving the demand for mRNA vaccines and therapeutics

4.2.2 Technological advancements in mRNA technology leading to the development of more effective and targeted treatments

4.2.3 Growing investments in research and development by pharmaceutical companies and government agencies to support mRNA vaccine and therapeutics development

4.3 Market Restraints

4.3.1 High manufacturing costs associated with mRNA vaccines and therapeutics impacting affordability and accessibility

4.3.2 Regulatory challenges and approval processes for mRNA-based products delaying market entry and commercialization

4.3.3 Concerns around long-term safety and efficacy of mRNA vaccines and therapeutics limiting widespread adoption

5 United States (US) mRNA Vaccine and Therapeutics Market Trends

6 United States (US) mRNA Vaccine and Therapeutics Market, By Types

6.1 United States (US) mRNA Vaccine and Therapeutics Market, By Vaccine Type

6.1.1 Overview and Analysis

6.1.2 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F

6.1.3 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F

6.1.4 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F

6.2 United States (US) mRNA Vaccine and Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F

6.2.3 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.4 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F

6.2.5 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F

6.3 United States (US) mRNA Vaccine and Therapeutics Market, By Treatment Type

6.3.1 Overview and Analysis

6.3.2 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F

6.3.3 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.3.4 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3.5 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F

6.4 United States (US) mRNA Vaccine and Therapeutics Market, By End user

6.4.1 Overview and Analysis

6.4.2 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F

6.4.3 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.4 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.5 United States (US) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics

7.1 United States (US) mRNA Vaccine and Therapeutics Market Export to Major Countries

7.2 United States (US) mRNA Vaccine and Therapeutics Market Imports from Major Countries

8 United States (US) mRNA Vaccine and Therapeutics Market Key Performance Indicators

8.1 Research and development investment in mRNA technology advancements

8.2 Number of clinical trials and pipeline development for mRNA vaccines and therapeutics

8.3 Adoption rate of mRNA-based treatments in healthcare settings

9 United States (US) mRNA Vaccine and Therapeutics Market - Opportunity Assessment

9.1 United States (US) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

9.2 United States (US) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.4 United States (US) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F

10 United States (US) mRNA Vaccine and Therapeutics Market - Competitive Landscape

10.1 United States (US) mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024

10.2 United States (US) mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa mRNA Vaccine and Therapeutics Market

Equatorial Guinea mRNA Vaccine and Therapeutics Market

Estonia mRNA Vaccine and Therapeutics Market

Ethiopia mRNA Vaccine and Therapeutics Market

Fiji mRNA Vaccine and Therapeutics Market

Finland mRNA Vaccine and Therapeutics Market

Global mRNA Vaccine and Therapeutics Market

Middle East mRNA Vaccine and Therapeutics Market

North America mRNA Vaccine and Therapeutics Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here